EU TRANSPARENCY REGISTER · 284240398066-67 · United States

SIGA Technologies, Inc.

Category

Companies & groups

Country

United States

New York

Entity form

For-profit corporation

Stated objectives

SIGA is a biopharmaceutical company whose objective is to develop medicines to prevent and treat emerging infectious diseases with high unmet medical needs. Smallpox, mpox, and other orthopoxviruses are particularly worrisome because they a…

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2025-04-28

Last updated

2026-04-03

Other Companies & groups in United States

Other registered organisations in United States

Frequently asked questions

What is this organisation?
SIGA Technologies, Inc. is an interest representative listed in the EU Joint Transparency Register under ID 284240398066-67. Entity form: For-profit corporation.
What category is it registered under?
It is registered under the category "Companies & groups".
Which country is it based in?
The organisation is based in United States, New York.
What are its stated goals?
As declared by the registrant: SIGA is a biopharmaceutical company whose objective is to develop medicines to prevent and treat emerging infectious diseases with high unmet medical needs. Smallpox, mpox, and other orthopoxviruses are particularly worrisome because they a…
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 284240398066-67.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-09 · Commission Reuse Decision 2011/833/EU